P&G Hygiene and Healthcare
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Procter & Gamble Hygiene and Health Care (PGHH) is navigating a challenging landscape characterized by persistent macroeconomic inflation and soft demand, particularly in rural and urban markets. Management's commitment to an 'Integrated Growth Strategy' emphasizes innovation and premiumization, particularly in the feminine hygiene segment, which is crucial for maintaining market share and driving long-term growth. However, the company faces significant margin pressure, with recent results indicating a 930 basis point year-over-year contraction in EBITDA margins due to rising commodity costs and increased advertising expenditures. Analysts have adjusted EPS estimates downward, reflecting a cautious outlook for FY27 and FY28. Despite these headwinds, PGHH's focus on operational productivity and brand superiority positions it to capture market share in a mature industry. The current financial outlook anticipates revenue contraction and continued margin pressure, aligning with Vista's valuation as a potential value trap. Over the next 12-24 months, key opportunities include leveraging brand loyalty and innovation, while watchpoints include macroeconomic volatility and competitive intensity in the FMCG sector
Why We Like This Stock
- Management's 'Integrated Growth Strategy' prioritizes innovation and premiumization, particularly in the feminine hygiene segment
- Strong brand loyalty and operational productivity initiatives provide a foundation for capturing market share
- The company's focus on long-term value creation through targeted investments positions it favorably despite current challenges
Things To Watch Out For
- Persistent macroeconomic inflation and soft demand are pressuring revenue and margins
- Recent EBITDA margin contraction of 930 basis points highlights significant cost pressures
- Analysts have revised EPS estimates downward, indicating a cautious outlook for the near term
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 4,206 | 3,374 | 4,290 | 4,195 | 4,468 |
| Profit Before Tax (Cr.) | 945 | 862 | 1,167 | 1,122 | 1,199 |
| PBT Margin | 22.5% | 25.5% | 27.2% | 26.8% | 26.8% |
| Net Profit (Cr.) | 681 | 645 | 867 | 830 | 887 |
| Earnings Per Share | 209.7 | 198.8 | 267.1 | 255.6 | 273.2 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Motilal Oswal | ► Neutral | 9,500 | 30-Jul-2026 |
Company Overview
Show Company Profile
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.